Wogonin inhibits N-acetyltransferase activity and gene expression in human leukemia HL-60 cells

Anticancer Research

Volumn 25, Issue 1 A, 2005, Pages 127-132

  Yu, Chun Shu ^a   Yu, Fu Shun ^a   Chuang, Yao Chen ^b   Lu, Hsu Feng ^c   Lin, Shuw Yun ^d   Chiu, Tsan Hung ^e   Chung, Jing Gung ^a  

^a CHINA MEDICAL UNIVERSITY   (Taiwan)

^b CHUNGTAI INST HLTH SCI TECHNOL   (Taiwan)

^c CHENG HSIN REHABILITATION MEDICAL CENTER   (Taiwan)

^d HUNGKUANG UNIVERSITY   (Taiwan)

^e CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

2 aminofluorene; Human leukemia cells; N acetyl 2 aminofluorene; N acetyltransferase; Wogonin

Indexed keywords

2 FLUORENYLAMINE; ACYLTRANSFERASE INHIBITOR; AROMATIC AMINE; CARCINOGEN; WOGONIN;

ACETYLATION; ARTICLE; CONTROLLED STUDY; DNA ADDUCT; DNA MICROARRAY; DOSE RESPONSE; DRUG ACTIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; GENE EXPRESSION; GENE EXPRESSION REGULATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; LABORATORY DIAGNOSIS; LEUKEMIA CELL; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; WESTERN BLOTTING;

2-ACETYLAMINOFLUORENE; ACETYLATION; ACETYLTRANSFERASES; CYTOSOL; DNA ADDUCTS; DOSE-RESPONSE RELATIONSHIP, DRUG; DOWN-REGULATION; ENZYME INHIBITORS; FLAVANONES; FLUORENES; GENE EXPRESSION; HL-60 CELLS; HUMANS; RNA, MESSENGER;

EID: 16344383829     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Weber WW: The Acetylator Genes and Drug Response, Oxford University press, NewYork: pp. 21-55, 1987.
2. Dybing E and Huitfeldt MS: Species differences in carcinogen metabolism and interspecies extrapolation. IARC Scientific Publications 116: 501-522, 1992.
3. Lang NP, Chu DZJ, Hunter CF, Kendall DC, Flamang TJ and Kadlubar FF: Role of aromatic amine acetyltransferase in human colorectal cancer. Arch Surg 121: 1259-1261, 1986.
4. Iletti KF, David BM, Detchon P, Castledon WM and Kwa R: Acetylator phenotype in colorectal carcinoma. Cancer Res 47: 1466-1469, 1987.
5. Roberts-Thomson IC, Ryan P, Khoo KK, Hart WJ, McMicha AJ and Burtler RN: Diet, acetylator phenotype, and risk of colorectal neoplasia. Lancet 347: 1371-1374, 1996.
6. Chen J, Stampfer MJ, Hough HL, Garcia-Closas M, Willett WC, Hennekens CH, Kelsey KT and Hunter DJ: A prospective study of N-acetyltransferase genotype, red meat intake, and risk of colorectal cancer. Cancer Res 58: 3307-3311, 1998.
7. Cartwright RA, Glasham RW, Rogers HJ, Ahmed RA, Barham-Hall D, Higgens E and Kahn MA: Role of N-acetyltransferase phenotype in bladder carcinogenesis: a pharmacologenetic epidemiological approach to bladder cancer. Lancet 2: 842-846, 1982.
8. Risch A, Wallace DM, Bathers S and Sim E: Slow N-acetyltransferase genotype is a susceptibility factor in occupational and smoking related bladder cancer. Hum Mol Genet 4: 231-236, 1995.
9. Brockmoller J, Cascorbi I, Kerb R and Roots I: Combined analysis of inherited polymorphisms in arylamine N-acetyltransferase 2, glutathine-S- transferase M1 and T1, microsomal epoxide hydrolase, and cytochrome P450 enzymes as modulators of bladder cancer risk. Cancer Res 56: 3915-25, 1996.
10. Lim BO: Effects of wogonin, wogonsides, and 3,5,7,2',6'- pentahydroxyflavone on chemical mediator production in peritoneal exduate cells and immunoglobulin E of rat mesenteric lymph node lymphocytes. J Enthnopharmacol 84: 23-29, 2003.
11. Lim BO, Choue RW, Lee HY, Seong NS and Kim JD: Effect of the flavonoid components obtained from Scutellaria radix on the histamine, immunoglobulin E and lipid peroxidation of spleen lymphocytes of Sprague-Dawley rats. Biosci Biotechnol Biochem 67: 1126-1129, 2003.
12. Chi YS, Lim H, Park H and Kim HP: Effects of wogonin, a plant flavone from Scutellaria radix, on skin inflammation: in vivo regulation of inflammation-associated gene expression. Biochem Pharmacol 66: 1271-1278, 2003.
13. Lee H, Kim YO, Kim H, Kim SY, Noh HS, Kang SS, Cho GJ, Choi WS and Suk K: Flavonoid wogonin from medicinal herb is neuroprotective by inhibiting inflammatory activation of microglia. FASEB J 17: 1943-1944, 2003.
14. Nakamura N, Hayasaka S, Zhang XY, Nagaki Y, Matsumoto M, Hayasaka Y and Terasawa K: Effects of baicalin, baicalein, and wogonin on interleukin-6 and interleukin-8 expression, and nuclear factor-kappaB binding activities induced by interleukin-1beta in human retinal pigment epithelial cell line. Exp Eye Res 77: 195-202, 2003.
15. Li DR, Hou HX, Zhang W and Li L: Effects of wogonin on inducing apoptosis of human ovarian cancer A2780 cells and telomerase activity. Ai Zheng 22: 801-805, 2003.
16. Chung JG, Li YC, Lee YM, Lin JP, Cheng KC and Chang WC: Aloe-emodin inhibited N-acetylation and DNA adduct of 2-aminofluorene and arylamine N-acetyltransferase gene expression in mouse leukemia L 1210 cells. Leukemia Res 27: 831-840, 2003.
17. Su CC, Chen GW, Yeh CC, Yang MD, Hung CF and Chung JG: Luteolin induces N-acetylation and DNA adduct of 2-aminofluorene accompanying N-acetyltransferase activity and gene expression in human bladder cancer T24 cell line. Anticancer Res 23: 355-362, 2003.
18. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976.
19. Chung JG: Effects of butylated hydroxyanisole (BHA) and butylated hydroxytoluene (BHT) on the acetylation of 2-aminofluorene and DNA-2-aminofluorene adducts in the rat. Toxicol Sci 57: 202-210, 1999.
20. Chung JG, Chang HL, Lin WC, Wang HH, Yeh CC, Hung CF and Li YC: Inhibitory of N-acetyltransferase activity and DNA-2-aminofluorene adducts by glycyrrhizic acid in human colon tumour cells. Food Chemi Toxicol 38: 163-172, 2000.
21. Chung JG, Yeh KT, Wu SL, Hsu NY, Chen GW, Yeh YW and Ho HC: Novel transmembrane GTPase of non-small cell lung cancer identified by mRNA differential display. Cancer Res 61: 8873-8879, 2001.
22. Chung JG, Lu HF, Yeh CC, Cheng KC, Lin SS and Lee JH: Inhibition of N-acetyltransferase activity and gene expression in human colon cancer cell lines by diallyl sulfide. Food Chemi Toxicol 42: 195-202, 2003.
23. Chen JG, Hwang JM, Chen GW, Tsou MF, Hsia TC and Chung JG: Curcurmin decreases the DNA adduct formation, arylamines N-acetyltransferase activity and gene expression in human colon tumor cells (colo 205). In Vivo 17: 301-310, 2003.
24. Lu KH, Lin KL, Yang CC, Hsia TC, Hsiao YM, Chou MC, Ho HC and Chung JG: The effect of paclitaxel on gene expression and activity of arylamine N-acetyltransferase and DNA-2-aminofluorene adduct formation in human leukemia HL-60 cells. Food Chem Toxicol 40: 705-13, 2002.
25. Weber WW and Hein DW: N-acetylation pharmacogenetics. Pharmacol Rev 37: 25- 99, 1985.
26. Einisto P, Watanabe M, Ishidate M and Nohmi T: Mutagenicity of 30 chemicals in S. typhimurium possessing different nitroreductase or O-acetyltransferase activities. Mutation Res 259: 95-102, 1991.
27. Grant DM, Blum M, Beer M and Meyer UA: Monomorphic and polymorphic human arylamine N-acetyltransferase: a comparison of liver isozymes and expressed products of two cloned genes. Mol Pharmacol 39: 184-191, 1991.
28. Minchin RF, Reeves PT, Teitel CH, McManus ME, Mojarrabi T, Ilett KF and Kadlubar FF: N-and O-acetylation of aromatic and heterocyclic amine carcinogens by human monomorphic and polymorphic acetyltransferase expressed in COS-1 cells. Biochem Biophys Res Commun 185: 839-844, 1992.
29. Smith G, Stanley LA, Sim E, Strange RC and Wolf CR: Metabolic polymorphisms and cancer susceptibility. Cancer Surv 25: 27-65, 1995.
30. Shih DE, Liu LT and Lin CC: Antioxidant and free radical scavenging effects of baicalein, baicalin and wogonin. Anticancer Res 20: 2861-2866, 2000.
31. 2+- dependent endonuclease. Biochem Pharm 63: 225-236, 2002.
32. Thorgeirsson SS, Glowinski IB and McManus ME: Metabolism, mutagenicity, carcinogenicity of aromatic amines. In: Hodgson J, Bend J and Philpot RM (Eds.,), Reviews in Biochemical Toxicity, Vol. 6, Elsevier/North Holland Biomedical Press, New York pp. 349-386, 1983.
33. Hayes MA, Roberts E, Safe SH, Farber E and Cameron RG: Influences of different polychlorinated biphenyls on cytocidal, mitoinhibitory, and nodule-selecting activities of N-2-fluorenylacetamide in rat liver. JNCI 76: 683-690, 1986.
34. Evans DAP: N-acetyltransferase. Pharmacol Ther 42: 157-234, 1989.
35. Campbell DA, Schoenwald RD, Duffel MW and Barknecht CF: Characterization of arylamine acetyltransferase in the rabbit eye. Invest Opththamol Vis Sci 32: 2190-2200, 1991.